Email
Password
Remember meForgot password?
Log in with Facebook Log in with Twitter
Connect your Digital Journal account with Facebook or Twitter to use this feature.
Connect
Log In Sign Up
In the Media

article imageFDA asks U.S. Marshals to seize ultrasound gel, bacteria found

article:323229:7::0
By Leigh Goessl
Apr 18, 2012 in Health
Share
Newark - U.S. Marshals have been asked to seize an ultrasound product from a N.J.-based company by the U.S. Food & Drug Administration after the agency found bacteria-contaminated samples.
According to an FDA press release, the agency asked the U.S. Marshals to seize specified lots of Other-Sonic Generic Ultrasound Transmission Gel, manufactured by Pharmaceutical Innovations Inc.
The facility is located in Newark, N.J.
This type of gel is used in conjunction with ultrasound imaging. The FDA decided to take the product out of circulation after it found bacteria in product samples that were collected in Feb. 2012.
The FDA is confiscating all lots of Other-Sonic Generic Ultrasound Transmission Gel that were manufactured between June 2011 and Dec. 2011. The product was found to be contaminated with what was described by the agency as two "dangerous" strains of bacteria, Pseudomonas aeruginosa and Klebsiella oxytoca. Additionally, the agency said the gel is misbranded and unsafe when used "in the manner suggested in the labeling."
“This ultrasound gel presented serious health risks to patients, particularly vulnerable ones,” said Dara A. Corrigan, the FDA’s associate commissioner for regulatory affairs in the press release. “Therefore, FDA, with the assistance of our state partner, is taking aggressive enforcement action to protect the public health.”
Prior to the U.S. Marshals seizing the gel product, the FDA requested the New Jersey Dept. of Health to hold the items under embargo.
FDA is warning medical personnel to cease using Other-Sonic Generic Ultrasound Transmission Gel manufactured in the noted date range due to health risks the product poses. The agency issued a safety alert to hospitals, doctors and other medical-related offices and businesses. In the alert, the FDA provided medical professionals with the affected lot numbers and product packaging descriptions, and also contains a section entitled "Summary of Problem and Scope" to outline the issues.
Sixteen people have reportedly developed health issues related to the bacteria contained in the ultrasound gel, either experiencing an infection or a colonization of bacteria.
article:323229:7::0
More about Fda, US Food and Drug Administration, US Marshals, ultrasound gel, Other Sonic Generic Ultrasound Transmission Gel
More news from
Latest News
Top News
Engage

Corporate

Help & Support

News Links

copyright © 2014 digitaljournal.com   |   powered by dell servers